click below
click below
Normal Size Small Size show me how
CMB-Chapter 18
CMB - Chapter 18 - Sterile Product Compounding & USP Chapter 797
| Question | Answer |
|---|---|
| On what date was the first United States Pharmacopeia (USP) Chapter 797 published? | January 1, 2004 |
| USP Chapter 797 contained the first | enforceable sterile preparation compounding requirements in the US |
| On what date was USP Chapter 797 revised | June 1, 2008 |
| the June 1, 2008 revisions of the USP Chapter 797 included | hazardous drugs, updated risk level classifications, updated garbing techniques |
| NABP | National Association of Boards of Phamracy |
| ASHP | American Society of Health-System Pharmacists |
| CSP | compounding sterile preparations |
| These two organizations may enforce guidelines developed by USP | FDA & JCAHO |
| PCAB | Pharmacy Compounding Accreditation Board |
| USP Chapters 1 through 999 are | considered requirements & enforceable by the FDA |
| USP Chapters 1000 through 1999 are | informational & additional non-enforceable recommendations |
| USP Chapters 2000 & above apply to | nutritional supplements |
| Some injectable medications must be compounded in a pharmacy because | dosages are customized for each patient, some drugs are stable for only short periods of time |
| The process used to avoid contamination while compounding sterile products is known as | "aseptic technique" |
| For injectable drugs, there are three primary routes of administration | SubQ, IM, & IV |
| SubQ, SQ, or SC) injections consist of | very small volumes of fluid (usually less than one or two mL) given just below the skin using a fine, short needle |
| Intramuscular (IM) injections employ | small volumes of fluid & are delivered deep into muscle tissue by longer & larger-bore needles |
| Intravenous (IV) injectable are | delivered directly into the vein |
| IV push | medication delivered all at once |
| continuous infusion | medication delivered slowly over a longer period of time, perhaps up to several hours or even days |
| Intra-peritoneal (IP) is | an injection into the peritoneal cavity (abdominal) of the body |
| IP is more commonly used in | animals |
| In humans, IP administration has been used as a means of | dialysis or administration of chemotherapy agents |
| TPN | Total parenteral nutrition |
| Total parenteral nutrition (TPN) is used when | patients cannot consume food or nutritional formula (like Ensure) for a prolonged period of time |
| A patient with a resistant or chronic infection may need | IV antibiotics |
| PCA | patient controlled analgesia |
| patient controlled analgesia (PCA) device | patients regulate the frequency of administration of their own pain medication |
| Small-volume parenterals contain | just enough fluid volume to safely deliver the medication into a patient's vein |
| When a small-volume parenteral is compounded, the ?, ?, ?, and ? all must be calculated & double checked prior to beginning the compounding process | correct drug, dose, dilution solution, number of doses |
| Many small-volume parenterals are delivered into the vein at the same time as another fluid, this is considered | "on piggyback" |
| Large-volume parenterals are used when | the fluid itself is the treatment |
| prescriptions for small-volume parenterals specify | the frequency of administration |
| prescriptions for large-volume parenterals specify | the rate of administration |
| All parenteral medications must be | sterile |
| The "critical area" is defined as | at least 6 inches within the laminar air flow hood |
| The critical area should be ISO Class | 5 or better |
| The buffer area is from | the room entrance to the 6 inch mark within laminar air flow hood |
| The buffer area should be ISO Class | 7 or better |
| The anteroom or preparation room is the room | just before the buffer area |
| The anteroom should be ISO Class | 8 or better |
| The two basic types of laminar-flow hoods | horizontal and vertical |
| Barrier isolators are | closed devices & compounders are completely isolated from the compounded sterile product |
| To maintain sterility, while working in a horizontal laminar-flow hood you must | always keep your hands & any nonsterile materials or supplies "downwind" from the product |
| one disadvantage of horizontal laminar-flow hoods | they blow a mild current of air directly at the person doing the compounding, resulting in repeated contact with medications |
| vertical laminar-flow hood is also known as a | biological safety cabinet |
| In a horizontal laminar-flow hood the clean air blows | from the filter toward the person working in the hood |
| In a vertical laminar-flow hood the clean air blows | straight down toward the work surface & is exhausted by a vent which surrounds the work surface. |
| sterile preparations compounded using non-sterile ingredients are always considered | high risk |
| High risk= | starting ingredients are non-steril, prep time is more than 6 hours, ingredients used >3, entries >2, & batch prep. |
| Immediate use= | starting ingredients are steril, prep time is several minutes to less than 1hr, ingredients used < or = 3, entries < or = 2, & non-batch prep. |
| BUD | beyond-use date |
| Low-risk CSPs with a 12-hour or less BUD are not required to | have an anteroom or ante area with ISO class 8 |
| Low-risk CSPs are generally prepared for a | one-time dose, for one patient |
| Medium-risk CSPs are generally | batch preparations |
| High-risk CSPs are | sterile products compounded from non-sterile bulk ingredients or powders |
| CSPs are considered high risk if | exposed to an environment worse than an ISO Class 5 for over 1 hour |
| An example of an event where an immediate use CSP is necessary is during | CPR |
| Remember, hazardous CSPs shall ALWAYS be prepared in | vertical laminar flow hoods (biological safety cabinets) or barrier isolators |
| If the Immediate use CSP is not administered within 1 hour, the CSP must be | discarded |
| If the CSP is not administered immediately & completely, the CSP shall include a label listing the following | Patient id info, Names & amounts of all ingredients, Name/initials of the preparer, Exact 1-hour BUD time |
| Examples of hazardous medications include those used in cancer, such as | methotrexate, cyclophosphamide, and fluorouracil |
| Hazardous preparations are also recommended to be stored in a | negative-pressure room |
| Environmental sampling will be done initially and then at intervals of | at least every 6 months |
| NIOSH | National Institute for Occupational Safety and Health |
| OSHA | Occupational Safety and Health Administration |
| The Occupational Safety Act of 1970 created | OSHA & NIOSH |
| OSHA is part of | the U.S. Department of Labor |
| NIOSH is part of | the U.S. Department of Health & Human Services |
| most important step to becoming compliant with USP guidelines | Training personnel on aseptic technique, hand washing, and proper garbing (least expensive) |
| 2nd most important step to becoming compliant with USP guidelines | Personal evaluation |
| 3rd most important step to becoming compliant with USP guidelines | Monitoring for surface microbial contamination, temperature, and humidity |
| 4th most important step to becoming compliant with USP guidelines | Review primary engineering controls (e.g., laminar flow hoods) |
| 5th most important step to becoming compliant with USP guidelines | Remodeling facilities, updating cleaning & disinfecting procedures |
| every time you have to handle objects outside of the hood, you must | wash your hands again before putting them back in the sterile environment of the hood |
| Laminar flow hoods & barrier isolators are to be cleaned when | at the beginning of each shift, before each batch preparation, every 30 minutes during continuous compounding of a single CSP, and when contamination is suspected |
| Counters and work surfaces located in the buffer area and the anterooms are to be cleaned | daily |
| Parenteral nutrition solutions administered peripherally are usually used as | a supplemental source of protein and calories for patients who are able to take some nutrition orally |
| TPNs are typically given via a | central line |
| TPNs are composed of several ingredients including | carbohydrates, proteins, fats, water, electrolytes & other elements |
| Machines such as ? and ? use specific gravity and weights to fill TPN orders | AutoMix and Exacta-Mix |
| Physical incompatibilities result in a | noticeable visual change such as precipitate, color, cloudiness, or gas production. |
| Chemical incompatibilities occur when a | product's composition is compromised often due to the presence of light or extreme temperature changes. |
| Therapeutic incompatibilities are | interactions between medications that cause a change in the activity of either one or both of the medications. |
| Beyond-use dating (BUD) is defined as | the time from the end of the preparation to the beginning of administration of a CSP |
| I define Beyond-use dating (BUD) as | I make it, you take it time! |
| low risk BUD | 48hrs Room; 14d Refer; 45d freezer |
| low risk w/12hr BUD | 12h room; 12h refer |
| med. risk BUD | 30h room; 9d refer; 45d freezer |
| high risk BUD | 24h room; 3d refer; 45d freezer |
| immediate use BUD | 1h room; 1h refer |
| Single-dose containers have the following BUD | air of quality inferior to ISO Class 5:BUD less than 1 hr - ISO Class 5 air quality or better: BUD of 6hr |
| Multidose containers have the following BUD | Opened or needle-punctured: BUD of 28 days |
| Sterile compounding requires a great deal of documentation, such as | compounding process, materials used, controlled subs, inventory records, clean room maint, QA & QC, & patient records |
| Labels for sterile products usually contain the following | pharmacy name, address, and telephone number, Patient name, Prescription date, prescriber name, Compounding date, Medication/additive name & strength, Diluent name & volume, Final volume, Sig/directions, Admin instruct, Date & time for admin of med, Pharm |
| An ? may be used in TPN compounding. This device combines a pump with an accurate balance | automated compounder |
| A ? pump can ease the job of filling many small volume parenterals | repeater |
| filter needles are used when | medication from an ampule is used |